The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: An open-label trial

Neuropsychobiology

Volumn 54, Issue 3, 2007, Pages 195-200

  Merlino, Giovanni ^a   Dolso, Pierluigi ^a   Canesin, Roberto ^a   Cancelli, Iacopo ^a   Valente, Mariarosaria ^a,b   Gigli, Gian Luigi ^a,b  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Cycling alternating pattern; Periodic leg movements; Pramipexole; Restless legs syndrome

Indexed keywords

PRAMIPEXOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SENSATION; SLEEP; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; BENZOTHIAZOLES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; SLEEP STAGES; TREATMENT OUTCOME;

EID: 33847764053     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099947     Document Type: Article

References (21)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health in collaboration with members of the International Restless Legs Syndrome Study Group: Restless Legs Syndrome: diagnostic criteria, special considerations, and epidemiology. - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119.
2. Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L: Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286-1292.
3. Montplaisir J, Nicolas A, Regine D, Gomez-Mancilla B: Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-943.
4. Saletu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B: Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 2002;252:185-194.
5. Partinen M, Hirvonen K, Jama L, Alakujiala A, Hublin C, Tamminen I, Koester J, Reess J: Efficacy and safety of pramipexole on idiopathic restless legs syndrome: a polysomnographic dose-finding study - The PRELUDE study. Sleep Med 2006;7:407-417.
6. Winkelman JW, Sethi KD, Kushida CS, Becker PM, Koester J, Cappola JJ, Reess J: Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2006;67:1034-1039.
7. Parrino L, Boselli M, Buccino GP, Spaggiari MC, Di Giovanni G, Terzano MG: The cycling alternating pattern plays a gate-control on periodic limb movements during nonrapid eye movement sleep. J Clin Neurophysiol 1996;13:314-323.
8. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C; International Restless Legs Syndrome Study Group: Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132.
9. Zucconi M, Ferri R, Allen RP, Baier BC, Bruni O, Chokroverty S, Ferini-Strambi L, Fulda S, Garcia-Borreguero D, Hening W, Hirshkowitz M, Hogl B, Hornyak M, King M, Montagna P, Parrino L, Plazzi G, Terzano MG: The official Word Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and in wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 2006;7:175-183.
10. American Sleep Disorders Association: EEG arousals: scoring rules and examples - A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-184.
11. Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, Brain Information Service/Brain Research Institute, University of California at Los Angeles, 1968.
12. Terzano MG, Parrino L, Smerieri A, Chervin R, Chokroverty S, Guilleminault C, Hirshkowitz M, Mahowald M, Moldofsky H, Rosa A, Thomas R, Walters A: Atlas, rules, and recording techniques for the scoring of cycling alternating pattern (CAP) in human sleep. Sleep Med 2001;2:237-253.
13. Lin SC, Kaplan J, Burger CD, Fredrickson PA: Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc 1998;73:497-500.
14. Becker PM, Ondo W, Sharon D: Encouraging initial response of restless legs syndrome to pramipexole. Neurology 1998;51:1221-1223.
15. Stiasny-Kolster K, Oertel WH: Low-dose pramipexole in the management of restless legs syndrome. Neuropsychobiology 2004;50:65-70.
16. Terzano MG, Parrino L, Fioriti G, Orofiamma B, Depoortere H: Modifications of sleep structure induced by increasing levels of acoustic perturbation in normal subjects. Electroencephalogr Clin Neurophysiol 1990;76:29-38.
17. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P: Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65.
18. Oertel W, Staisny-Kolster K: Early and persistent effect of pramipexole in restless legs syndrome (RLS) patients already with the starting dose. Mov Disord 2005;20(suppl10):S58
19. Montplaisir J, Boucher S, Gosselin A, Poirier G, Lavigne G: Persistence of repetitive EEG arousals (K-alpha complexes) in RLS patients treated with L-dopa. Sleep 1996;19:196-199.
20. Clemens S, Rye D, Hochman S: Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006;67:125-130.
21. Scharf MB, Stover R, McDannold M, Kaye H, Berkowitz DV: Comparative effects of sleep on a standard mattress to an experimental foam surface on sleep architecture and CAP rates. Sleep 1997;20:1197-1200.